Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Horbinski

Showing results (91-100 of 209) with videos related to

Pageof 21
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
VTE incidence shortens survival in IDH-WT glioblastomaAnthony R Sloan, Alan J Gordillo, Austin Kennemer, et al.
Neuro-Oncology Advances|April 23, 2025
Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastomaAnthony R Sloan, Alan J Gordillo, Austin Kennemer, et al.
Neuro-Oncology|March 29, 2023
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesisAnshika Goenka, Xiao Song, Deanna Tiek, et al.
Journal of Neuropathology and Experimental Neurology|June 3, 2020
Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?Kwok Ling Kam, Christina L Appin, Qinwen Mao, et al.
Neuro-Oncology|April 26, 2023
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewJasmin Jo, Maria Diaz, Craig Horbinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine GlioblastomaC Elizabeth Boudreau, Hinda Najem, Martina Ott, et al.
Neuro-Oncology|December 10, 2024
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastomaMatthew McCord, Thomas Sears, Wenxia Wang, et al.
Neuro-Oncology|February 18, 2026
Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoformsRunxin Wu, Xiaozhou Yu, Xiao Song, et al.
American Journal of Medical Genetics. Part A|October 22, 2008
Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplicationCraig Horbinski, Erika M Carter, Patricia L Heard, et al.
Future Oncology (London, England)|January 9, 2025
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effectsBobak F Khalili, Tobias Walbert, Craig Horbinski, et al.
Pageof 21

Showing results (91-100 of 209) with videos related to

Sort By:
Pageof 21
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
VTE incidence shortens survival in IDH-WT glioblastomaAnthony R Sloan, Alan J Gordillo, Austin Kennemer, et al.
Neuro-Oncology Advances|April 23, 2025
Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastomaAnthony R Sloan, Alan J Gordillo, Austin Kennemer, et al.
Neuro-Oncology|March 29, 2023
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesisAnshika Goenka, Xiao Song, Deanna Tiek, et al.
Journal of Neuropathology and Experimental Neurology|June 3, 2020
Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?Kwok Ling Kam, Christina L Appin, Qinwen Mao, et al.
Neuro-Oncology|April 26, 2023
Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary reviewJasmin Jo, Maria Diaz, Craig Horbinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine GlioblastomaC Elizabeth Boudreau, Hinda Najem, Martina Ott, et al.
Neuro-Oncology|December 10, 2024
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastomaMatthew McCord, Thomas Sears, Wenxia Wang, et al.
Neuro-Oncology|February 18, 2026
Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoformsRunxin Wu, Xiaozhou Yu, Xiao Song, et al.
American Journal of Medical Genetics. Part A|October 22, 2008
Molecular and clinical characterization of a recurrent cryptic unbalanced t(4q;18q) resulting in an 18q deletion and 4q duplicationCraig Horbinski, Erika M Carter, Patricia L Heard, et al.
Future Oncology (London, England)|January 9, 2025
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effectsBobak F Khalili, Tobias Walbert, Craig Horbinski, et al.
Pageof 21